secwatch.observer — SEC 8-K summary
======================================

Issuer:     4D Molecular Therapeutics, Inc. (FDMT)
CIK:        0001650648
Form:       8-K
Filed at:   2025-06-20T23:59:59+00:00
Accession:  0000950170-25-088482
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

4D Molecular Therapeutics annual meeting results: all four proposals approved
-----------------------------------------------------------------------------

- Stockholders elected Jacob Chacko, Susannah Gray, and Charles Theuer as Class II directors.
- Ratified PricewaterhouseCoopers as independent auditor for FY2025.
- Say-on-pay proposal approved (31.8M for, 394k against, 35k abstain, 6.2M broker non-votes).
- Advisory vote on future say-on-pay frequency: one year chosen; company will hold annual votes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1650648/000095017025088482/0000950170-25-088482-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1650648/000095017025088482/fdmt-20250617.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-088482

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer